Whipplewood Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.7K Sell
49
-181
-79% -$62K 0.01% 204
2026
Q1
$80.9K Buy
230
+225
+4,500% +$80.2K 0.04% 218
2025
Q4
$1.64K Buy
+5
New +$1.59K ﹤0.01% 357
2025
Q3
Sell
-381
Closed -$106K 340
2025
Q2
$106K Sell
381
-685
-64% -$194K 0.06% 228
2025
Q1
$117K Buy
1,066
+670
+169% +$198K 0.07% 208
2024
Q4
$103K Buy
+396
New +$117K 0.06% 227

Other funds holding AMGN

Whipplewood Advisors's AMGN Position: Q2 2026 in Review

Whipplewood Advisors reduced its Amgen (AMGN) stake by 79% in Q2 2026, selling an estimated $62K and leaving 49 shares worth $17.7K. The position accounts for 0.01% of the portfolio, ranked #204.

Whipplewood Advisors first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $117K in Q1 2025. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Whipplewood Advisors held 49 shares of Amgen worth $17.7K as of Q2 2026.
  • Whipplewood Advisors sold 181 Amgen shares in Q2 2026, an estimated $62K.
  • Amgen made up 0.01% of Whipplewood Advisors's portfolio in Q2 2026, its #204 holding.
  • Whipplewood Advisors first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • Whipplewood Advisors's Amgen position peaked at $117K in Q1 2025.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.